🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc. logo
Market Cap: Low
Employees: Lowest

galinpepimut-S (GPS)

SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focusing on the development of novel cancer immunotherapies in the United States. Their lead product candidate, galinpepimut-S (GPS), is in Phase III clinical trials for acute myeloid leukemia and Phase 1/2 for ovarian cancer.

Tags: acute myeloid leukemia, biopharmaceutical, breast cancer, cancer immunotherapies, clinical trials, ovarian cancer

Website

About | About | About | Careers | About | About

Symbol: SLS

Recent Price: $0.99

Industry: Biotechnology

CEO: Dr. Angelos M. Stergiou M.D., ScD h.c.

Sector: Healthcare

Employees: 16

Address: Times Square Tower, New York, NY 10036

Phone: 646 200 5278

Last updated: 2024-12-31